Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Rheum Dis. 1977 Feb;36(1):80-2.

Multicentre trial of naproxen and phenylbutazone in acute gout.

Abstract

Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.

PMID:
843115
PMCID:
PMC1006635
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center